Ellipticine
Ellipticine[edit]
Ellipticine is a naturally occurring alkaloid that has been studied for its potential anticancer properties. It is derived from the plant species Ochrosia elliptica, which is native to Australia and the Pacific Islands. Ellipticine is known for its unique planar structure, which allows it to intercalate into DNA, disrupting the function of topoisomerase enzymes and inhibiting DNA replication.
Chemical Properties[edit]
Ellipticine is classified as an indole alkaloid. Its chemical formula is C17H14N2, and it has a molecular weight of 246.31 g/mol. The compound is characterized by a fused ring system that includes an indole moiety, which is responsible for its ability to interact with DNA.
Mechanism of Action[edit]
Ellipticine exerts its biological effects primarily through DNA intercalation. By inserting itself between the base pairs of the DNA double helix, ellipticine disrupts the normal function of DNA polymerase and RNA polymerase, leading to the inhibition of DNA and RNA synthesis. Additionally, ellipticine can inhibit the activity of topoisomerase II, an enzyme crucial for DNA replication and cell division.
Pharmacological Effects[edit]
The anticancer activity of ellipticine has been demonstrated in various in vitro and in vivo studies. It has shown efficacy against a range of cancer cell lines, including those resistant to other chemotherapeutic agents. The compound induces apoptosis in cancer cells, a process of programmed cell death that is often defective in cancerous tissues.
Clinical Applications[edit]
While ellipticine has shown promise in preclinical studies, its clinical application has been limited due to issues with solubility and toxicity. Researchers are exploring various derivatives and formulations to improve its therapeutic index and reduce side effects. Some derivatives have entered clinical trials, aiming to harness the anticancer potential of ellipticine while minimizing adverse effects.
Related Compounds[edit]
Ellipticine is part of a broader class of compounds known as DNA intercalators, which includes other anticancer agents such as doxorubicin and daunorubicin. These compounds share a common mechanism of action but differ in their chemical structures and specific biological effects.
Related Pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
